Press / Special articles

Press / Special articles » Press releases

Detailed view

Date: 03.12.2012 10:05

An innovative option for the treatment of biphosphonate-associated osseous necrosis: HELBO® treatment

bredent medical GmbH & Co.KG
Weissenhorner Straße 2
89250 Senden
Tel: +49 (0) 7309 / 872-22
Fax: +49 (0) 7309 / 872-24
@: info@bredent.com


Contact person for the press:
Andreas Bischoff
Head of Marketing bredent group
Tel: +49 (0) 7309 / 872-396
Fax: +49 (0) 7309 / 872-605
@: andreas.bischoff@bredent.com